Lori Jeanne West

Title: Lori Jeanne West: Innovator in Immunologic Tolerance

Introduction

Lori Jeanne West is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of immunology, particularly in the area of inducing immunologic tolerance to non-self antigens. Her innovative work has the potential to impact transplantation medicine and improve patient outcomes.

Latest Patents

Lori Jeanne West holds a patent for "Methods and systems for inducing immunologic tolerance to non-self antigens." This patent describes methods and systems that can be utilized to induce immunologic tolerance to non-self antigens. The methods involve introducing a tolerogen that comprises at least one immunogenic non-self antigen coupled to a carrier. The immunogenic antigen can be a foreign or endogenous antigen or fragments thereof. The non-self antigen can be selected from carbohydrate antigens, full-length antigenic proteins, and their fragments and combinations. The carrier can include nanoparticles and stents. The tolerogen compositions provided can be used to induce immunologic tolerance, which is particularly advantageous for extending the window of safety for immunologically incompatible transplantations in patients beyond infancy.

Career Highlights

Lori Jeanne West is affiliated with the University of Alberta, where she continues her research and development in immunology. Her work has garnered attention for its innovative approach to addressing challenges in transplantation and immunologic responses.

Collaborations

Lori has collaborated with notable colleagues, including Todd Lambert Lowary and Jillian Mary Buriak. These collaborations have further enriched her research and contributed to advancements in the field.

Conclusion

Lori Jeanne West is a trailblazer in the field of immunology, with her patent on inducing immunologic tolerance showcasing her innovative spirit. Her contributions have the potential to transform transplantation practices and improve patient care.